CEACAM1 expression in pancreatic endocrine tumors.

CEACAM1 expression in pancreatic endocrine tumors.

The aim of this study was to examine the expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in pancreatic endocrine tumors (PETs) and to correlate it with clinicopathologic parameters. Sixty-nine PETs were examined for tumor size, necrosis, local peripancreatic invasio...

Full description

Bibliographic Details
Main Authors:	Serra, S, Asa, S, Bamberger, A, Wagener, C, Chetty, R
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Pancreatic endocrine tumors: an update.
by: Chetty, R, et al.
Published: (2004)

Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
by: Chetty, R, et al.
Published: (2008)

Pancreatic endocrine tumors with ductules.
by: Chetty, R, et al.
Published: (2005)

Intracytoplasmic inclusions (including the so-called "rhabdoid" phenotype) in pancreatic endocrine tumors.
by: Serra, S, et al.
Published: (2006)

The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
by: Ali, A, et al.
Published: (2006)

Spindle cell pancreatic endocrine tumor associated with Cushing's syndrome.
by: Chetty, R, et al.
Published: (2005)

Pancreatic endocrine tumour with ductules: further observations of an unusual histological subtype.
by: Chetty, R, et al.
Published: (2006)

The expression and modulation of CEACAM1 and tumor cell transformation
by: Valentina Fiori, et al.
Published: (2012-06-01)

Pancreatic endocrine tumour with cytoplasmic keratin whorls. Is the term "rhabdoid" appropriate?
by: Chetty, R, et al.
Published: (2004)

CEACAM7 expression contributes to early events of pancreatic cancer
by: Anupam Dhasmana, et al.
Published: (2024-01-01)

Pancreatic endocrine tumors with ductules [2] (multiple letters)
by: Chetty, R, et al.
Published: (2005)

Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions.
by: Chetty, R, et al.
Published: (2004)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
by: Goldenberg David M, et al.
Published: (2007-01-01)

Pancreatic endocrine neoplasia: familial syndromes
by: Chetty, R
Published: (2009)

Ductules in pancreatic neuroendocrine tumors.
by: Chetty, R, et al.
Published: (2004)

Role of CEACAM1 and CEACAM20 in an in vitro model of prostate morphogenesis.
by: Hui Zhang, et al.
Published: (2013-01-01)

CEACAM expression in an in-vitro prostatitis model
by: Irina Kube-Golovin, et al.
Published: (2023-08-01)

Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma
by: Jinge Xu, et al.
Published: (2018-02-01)

VHL expression in pancreatic adenocarcinomas
by: Serra, S, et al.
Published: (2009)

CEACAM1 Activation by CbpF-Expressing E. coli
by: Amjad Shhadeh, et al.
Published: (2021-07-01)

Soluble CEACAM8 interacts with CEACAM1 inhibiting TLR2-triggered immune responses.
by: Bernhard B Singer, et al.
Published: (2014-01-01)

Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1
by: Marcel Cerqueira Cesar Machado

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
by: Chamutal Gur, et al.
Published: (2019-06-01)

Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells.
by: Ning Wang, et al.
Published: (2014-01-01)

Structural analysis of human CEACAM1 oligomerization
by: Amit K. Gandhi, et al.
Published: (2022-09-01)

CEACAM1-Mediated Inhibition of Virus Production
by: Alon Vitenshtein, et al.
Published: (2016-06-01)

Lipid-rich variant of pancreatic endocrine neoplasms.
by: Singh, R, et al.
Published: (2006)

Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.
by: Couvelard, A, et al.
Published: (2006)

Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis
by: Haruki Matsumoto, et al.
Published: (2022-12-01)

The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes
by: Lee Wonae
Published: (2011-05-01)

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene
by: Lucia Russo, et al.
Published: (2018-03-01)

CEACAM1 recognition by bacterial pathogens is species-specific
by: Kammerer Robert, et al.
Published: (2010-04-01)

CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
by: Benediktas Kurlinkus, et al.
Published: (2021-06-01)

Combined Pancreatic Endocrine Tumor and Serous Cystadenoma
by: Min-Shu Hsieh, et al.
Published: (2009-09-01)

Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer
by: Haojun Shi, et al.
Published: (2022-12-01)

Expression Of TIM-3 And CEACAM-1 In Bladder Urothelial Carcinoma ( Immunohistochmical And Histopathological Study )
by: Abla Sayed Mahmoud, et al.
Published: (2021-06-01)

Antiplatelet effects of the CEACAM1-derived peptide QDTT
by: Yujia Ye, et al.
Published: (2024-12-01)

Altered splicing of CEACAM1 in breast cancer: Identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms
by: Yen Yun, et al.
Published: (2008-05-01)

Binding of <italic toggle="yes">Candida albicans</italic> to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
by: Esther Klaile, et al.
Published: (2017-05-01)

Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1
by: Bao-Ping Wang, et al.
Published: (2018-02-01)